Satoh Yuki | Nagoya City University
スポンサーリンク
概要
関連著者
-
FURUMOTO Tomoo
Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine
-
Satoh Yuki
Nagoya City University
-
Furumoto Tomoo
Department Of Cardiovascular Medicine Hokkaido University Graduate School Of Medicine
-
Imagawa Shogo
Hokkaido Univ. Sapporo
-
Iwakiri Naoki
Division Of Cardiology Kitami Red Cross Hospital
-
Fujii Satoshi
Cardiology Hokkaido University School Of Medicine
-
Ishimori Naoki
Department Of Cardiovascular Medicine Hokkaido University Graduate School Of Medicine
-
Tsutsui Hiroyuki
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Hokkaido University
-
Ando Yasuhiro
Department Of Cardiovascular Medicine Hokkaido University Graduate School Of Medicine
-
FUJII Satoshi
Department of Neurosurgery, Yokohama City University School of Medicine
-
Ishimori Naoki
Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine
-
Tsutsui Hiroyuki
Department Of Cardiovascular Medicine
-
Dong Jie
Department Of Cardiovascular Medicine Hokkaido University Graduate School Of Medicine
-
Imagawa Shogo
Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine
-
Togashi Hiroko
Department Of Pharmacology Hokkaido University Graduate School Of Medicine
-
Andoh Yasuhiro
Department of Cardiovascular Medicine, Hokkaido University
-
Ohmura Kazue
Department of Cardiovascular Medicine, Graduate School of Medicine, Hokkaido University
-
Togashi Hiroko
Safety Research Institute For Chemical Compounds
-
Fujii Satoshi
Department Of Applied Chemistry Faculty Of Engineering Himeji Institute Of Technology
-
Ohmura Kazue
Department Of Cardiovascular Medicine Hokkaido University Graduate School Of Medicine
-
Andoh Yasuhiro
Department Of Cardiovascular Medicine Hokkaido University
-
Andoh Yasuhiro
Department Of Cardiovascular Medicine Graduate School Of Medicine Hokkaido University
-
Ohmura Kazue
Department Of Cardiology Hokkaido University Hospital
-
TSUTSUI Hiroyuki
Department of Cardiology, Iizuka Hospital
-
SATO Yuki
Department of Quantum Science and Energy Engineering, Tohoku University
-
TSUTSUI Hiroyuki
Hokkaido University
-
Kaneko Takeaki
Department Of Metabolic Disease Tokyo University Graduate School Of Medicine
-
Togashi Hiroko
筑波大学 臨床医学系循環器内科
-
Togashi Hiroko
北海道大学 医学研究科 薬理
-
Togashi Hiroko
北海道大学
-
Togashi Hiroko
Department Of Pharmacology Hokkaido University School Of Medicine
-
Fujii Satoshi
Nagoya City University Graduate School of Pharmaceutical Sciences
-
Ohmura Yoshinori
Department of Cardiovascular Medicine, Graduate School of Medicine, Hokkaido University
-
Satoh Yuki
Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine
-
Sato Yuki
Nagoya City University
-
Furumoto Tomoo
Hokkaido Univ. Sapporo
-
Imagawa Syougo
Hokkaido Univ. Sapporo
-
Ishimori Naoki
Hokkaido Univ. Sapporo
-
Sato Yuki
Department Of Health Policy National Research Institute For Child Health And Development
-
Togashi Hiroko
Department Of Cardiovascular Medicine Hokkaido University Graduate School Of Medicine
-
Sato Yuki
Department Of Clinical Engineering Nagoya University Hospital
-
Sato Yuki
Department Of Chemistry Graduate School Of Science Tohoku University
-
Tsutsui Hiroyuki
Department Of Cardiovasucular Medicine Hokkaido University Graduate School Of Medicine
-
Fujii Satoshi
Nagoya City University
-
Fujii Satoshi
Department Of Molecular And Cellular Pathobiology And Therapeutics Nagoya City University Graduate School Of Pharmaceutical Sciences
-
Sato Yuki
Department Of Anesthesiology Jichi Medical School
-
Fujii Satoshi
Nagoya City Univ. Nagoya Jpn
著作論文
- Platelet Aggregability in Patients with Hypertension Treated with Angiotensin II Type 1 Receptor Blockers
- OJ-115 Hepatocyte Growth Factor and Its Signaling Pathways : Potential Mediators of Increased Plasminogen Activator Inhibitor Type-1 Expression Associated with Insulin Resistance(Thromboembolism/Antithrombotic therapy/Thrombolysis-2 (H) OJ20,Oral Presenta
- PE-581 Insulin Regulates Plasminogen Activator Inhibitor 1 Expression in Hepatocytes and in Mice Liver Through Statin-Sensitive Pathway(Thromboembolism/Antithrombotic therapy/Thrombolysis(03)(H),Poster Session(English),The 72nd Annual Scientific Meeting o